Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Protara Therapeutics, Inc. | 24,000 | reported | 12 Jun 2025 | tx 15+319,641 |
| Omega Therapeutics, Inc. | 18,118 | reported | 07 Jun 2023 | tx 3+89,177 |
| REGENXBIO Inc. | 10,000 | reported | 04 Jun 2021 | tx 41+148,666−133,166 |
| CAMBREX CORP | 0 | reported | 10 Oct 2007 | tx 76+391,258−480,638 |
| NPS PHARMACEUTICALS INC | 0 | reported | 21 Feb 2015 | tx 112+1,449,370−1,351,984 |
| Trillium Therapeutics Inc. | 0 | reported | 17 Nov 2021 | tx 3−594,322.26 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Protara Therapeutics, Inc. | 24,000 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Omega Therapeutics, Inc. | 18,118 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 30 Jun 2022 | PURCHASE | Protara Therapeutics, Inc. | 10,000 | 3.10 USD | |
| 08 Jun 2022 | GRANT_AWARD | Omega Therapeutics, Inc. | 18,118 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 14 Mar 2022 | PURCHASE | Protara Therapeutics, Inc. | 10,000 | 4.25 USD | |
| 10 Mar 2022 | PURCHASE | Protara Therapeutics, Inc. | 10,000 | 4.46 USD | first after silence |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 40,000 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 547,656.26 | — | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 6,666 | 0.00 USD | deriv |
| 29 Jul 2021 | GRANT_AWARD | Omega Therapeutics, Inc. | 52,941 | 0.00 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 09 Jun 2020 | GRANT_AWARD | Protara Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 29 May 2020 | GRANT_AWARD | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 10 Jan 2020 | GRANT_AWARD | Protara Therapeutics, Inc. | 168,000 | 0.00 USD | |
| 09 Jan 2020 | GRANT_AWARD | Protara Therapeutics, Inc. | 10,491 | — | deriv |
| 09 Jan 2020 | GRANT_AWARD | Protara Therapeutics, Inc. | 12,399 | — | deriv |
| 09 Jan 2020 | GRANT_AWARD | Protara Therapeutics, Inc. | 6,676 | — | deriv |
| 31 May 2019 | GRANT_AWARD | REGENXBIO Inc. | 10,000 | 0.00 USD | deriv |
| 29 Nov 2018 | EXERCISE | REGENXBIO Inc. | 12,784 | 3.76 USD | |
| 29 Nov 2018 | SALE | REGENXBIO Inc. | 12,784 | 65.00 USD | |
| 29 Nov 2018 | EXERCISE | REGENXBIO Inc. | 12,784 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 10 Mar 2022.